切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2020, Vol. 10 ›› Issue (06) : 339 -345. doi: 10.3877/cma.j.issn.2095-123X.2020.06.006

所属专题: 文献

基础研究

初步探索DIM-C-pPhOH(NR4A1拮抗剂)对胶质瘤细胞增殖、迁移及侵袭的抑制作用及作用机制
徐杨熙1, 黄海韬1, 马逸1, 王斌1, 王全才1, 李岩峰1,(), 周建波1, 董经宇1   
  1. 1. 110016 沈阳,辽宁省人民医院神经外科
  • 收稿日期:2020-05-16 出版日期:2020-12-15
  • 通信作者: 李岩峰

DIM-C-pPhOH(NR4A1 antagonist) can inhibit cell proliferation, migration and invasion by inducing autophagy in glioma

Yangxi Xu1, Haitao Huang1, Yi Ma1, Bin Wang1, Quancai Wang1, Yanfeng Li1,(), Jianbo Zhou1, Jingyu Dong1   

  1. 1. Department of Neurosurgery, the People’s Hospital of Liaoning Province, Shengyang 110016, China
  • Received:2020-05-16 Published:2020-12-15
  • Corresponding author: Yanfeng Li
引用本文:

徐杨熙, 黄海韬, 马逸, 王斌, 王全才, 李岩峰, 周建波, 董经宇. 初步探索DIM-C-pPhOH(NR4A1拮抗剂)对胶质瘤细胞增殖、迁移及侵袭的抑制作用及作用机制[J]. 中华脑科疾病与康复杂志(电子版), 2020, 10(06): 339-345.

Yangxi Xu, Haitao Huang, Yi Ma, Bin Wang, Quancai Wang, Yanfeng Li, Jianbo Zhou, Jingyu Dong. DIM-C-pPhOH(NR4A1 antagonist) can inhibit cell proliferation, migration and invasion by inducing autophagy in glioma[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2020, 10(06): 339-345.

目的

探索DIM-C-pPhOH(NR4A1拮抗剂)对胶质瘤细胞增殖、迁移、侵袭的抑制作用及其作用机制,以及对于胶质瘤小鼠模型生存期及肿瘤生长的影响。

方法

不同浓度DIM-C-pPhOH处理胶质瘤细胞系(GL261、U251、U118)48 h后,用CellTiter法检测细胞活性及IC50;采用划痕实验和3D-invasion实验检测DIM-C-pPhOH对U251细胞系侵袭迁移作用的影响;通过腹腔注射该化合物治疗小鼠胶质瘤模型,观察DIM-C-pPhOH对于小鼠胶质瘤生长以及生存期的影响。

结果

U251、GL261和U118胶质瘤细胞系经DIM-C-pPhOH处理48 h后,细胞活性随药物浓度增加显著降低,IC50分别为5.76、6.87、9.93 μmol/L;U251细胞系经10 μmol/L DIM-C-pPhOH处理后其迁移和侵袭能力显著下降;同时DIM-C-pPhOH可以抑制由TGF-β诱导的NR4A1出核表达;小鼠胶质瘤模型中DIM-C-pPhOH治疗组生存期延长,肿瘤生长受到抑制。蛋白免疫印迹显示DIM-C-pPhOH可以明显抑制Akt、P70S6K蛋白表达,通过抑制PI3K/Akt/mTOR/p70s6k信号通路,诱导细胞自噬发生。

结论

DIM-C-pPhOH可以抑制胶质瘤的迁移及侵袭能力,延长小鼠胶质瘤模型的生存期并抑制肿瘤生长,作用机制可能与DIM-C-pPhOH诱导细胞发生自噬有关。

Objective

To explore the inhibitory effect of DIM-C-pPhOH (NR4A1 antagonist) on proliferation, migration and invasion of glioma cells and its mechanism, as well as the effect on the survival time and tumor of glioma mouse model.

Methods

Cell viability of glioma cell lines (GL261, U251, U118) treated with DIM-C-pPhOH for 48 h and then detected cell viability and IC50 by CellTiter. The effect of DIM-C-pPhOH on invasion and migration of U251 cell line was studied by scratch experiment and 3D-invasion experiment. Meanwhile, DIM-C-pPhOH inhibited the TGF-β-induced nucleotide expression of NR4A1. Intraperitoneal injection of DIM-C-pPhOH in mice glioma model was used to simulate in vivo environment to observe the survival curve and its effect on tumor growth. Western blotting showed that DIM-C-pPhOH could significantly inhibit the expression of Akt and p70S6K proteins, and induce autophagy by inhibiting the PI3K/Akt/mTOR/p70S6K signaling pathway.

Results

After DIM-C-pPhOH treatment, the cell activity of glioma cell lines decreased significantly with the increase of drug concentration, and the IC50 of U251, GL261 and U118 gloma cell lines were 5.76, 6.87, and 9.93 μmol/L, respectively. The migration and invasion ability of U251 cells in glioma decreased significantly after DIM-C-pPhOH (10 μmol/L) treatment. In the mouse glioma model, the survival time of the drug treatment group was prolonged and tumor growth was inhibited. Western blotting showed that DIM-C-pPhOH could significantly inhibit the expression of Akt and P70S6K, and induce autophagy by inhibiting PI3K/Akt/mTOR/p70S6K signaling pathway.

Conclusion

DIM-C-pPhOH can reduce the migration and invasion of glioma, prolong the survival time of mouse glioma model and inhibit tumor growth. The underlying mechanism may be related to autophagy induced by DIM-C-pPhOH.

图1 不同浓度DIM-C-pPhOH对于不同胶质瘤细胞系细胞活性的影响
图2 DIM-C-pPhOH作用12、24 h后对U251细胞系迁移作用的影响
图3 DIM-C-pPhOH作用6、12 h后对U251细胞球的侵袭作用的影响
图4 DIM-C-pPhOH可以抑制TGF-β诱导的NR4A1基因出核表达
图5 DIM-C-pPhOH对小鼠胶质瘤模型肿瘤大小以及生存曲线
图6 DIM-C-pPhOH抑制U251细胞PI3K/Akt/mTOR/p70s6k信号通路,诱导细胞自噬发生
[1]
Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011[J]. Neuro Oncol, 2014, 16 Suppl 4(Suppl 4): iv1-iv63.
[2]
Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma[J]. CA Cancer J Clin, 2010, 60(3): 166-193.
[3]
Lin PC, Chen YL, Chiu SC, et al. Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor[J]. J Neurochem, 2008, 106(3): 1017-1026.
[4]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[5]
Ostrom QT, Gittleman H, Stetson L, et al. Epidemiology of gliomas[J]. Cancer Treat Res, 2015, 163: 1-14.
[6]
Pearson JRD, Regad T. Targeting cellular pathways in glioblastoma multiforme[J]. Signal Transduct Target Ther, 2017, 2: 17040.
[7]
Alexander BM, Cloughesy TF. Adult glioblastoma [J]. J Clin Oncol, 2017, 35(21): 2402-2409.
[8]
Safe S, Jin UH, Hedrick E, et al. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets[J]. Mol Endocrinol, 2014, 28(2): 157-172.
[9]
Lee SO, Abdelrahim M, Yoon K, et al. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth[J]. Cancer Res, 2010, 70(17): 6824-6836.
[10]
Lee SO, Andey T, Jin UH, et al. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53[J]. Oncogene, 2012, 31(27): 3265-3276.
[11]
Lee SO, Jin UH, Kang JH, et al. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells[J]. Mol Cancer Res, 2014, 12(4): 527-538.
[12]
京萍,曾令公,武世伍,等.细胞自噬在神经胶质瘤治疗中的研究进展[J].中国病理生理杂志, 2019, 35(5): 955-960.
[13]
Zhou F, Drabsch Y, Dekker TJ, et al. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling[J]. Nat Commun, 2014, 5: 3388.
[14]
Hedrick E, Lee SO, Doddapaneni R, et al. NR4A1 antagonists inhibit β1-integrin-dependent breast cancer cell migration[J]. Mol Cell Biol, 2016, 36(9): 1383-1394.
[15]
Hedrick E, Safe S. Transforming growth factor beta/NR4A1-inducible breast cancer cell migration and epithelial-to-mesenchymal transition is p38alpha (Mitogen-Activated Protein Kinase 14) dependent[J]. Mol Cell Biol, 2017, 37(18): e00306-e00317.
[1] 王晗宇, 张司可, 张羽, 万欣, 贺秋霞, 李明明, 杨秀华. 超声造影在脑胶质瘤切除术术中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 755-760.
[2] 李康, 冀亮, 赵维, 林乐岷. 自噬在乳腺癌生物学进展中的双重作用[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 195-202.
[3] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[4] 陈玲, 李楠, 杨建乐. 微小RNA-377-3p调控自噬改善脂多糖/D-半乳糖胺诱导的急性肝衰竭的机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(02): 89-97.
[5] 周子慧, 李恭驰, 李炳辉, 王知, 刘慧真, 王卉, 邹利军. 细胞自噬在创面愈合中作用的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 542-546.
[6] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[7] 邵浩仁, 郭佳. 铁死亡的分子机制及其在前列腺癌治疗中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 294-298.
[8] 程亚飞, 任长远, 李海马, 孙恺, 马亚群. FSTL1基因在胶质瘤发展中作用的研究[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 206-215.
[9] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[10] 冯海涛, 徐涛, 刘文阳, 孙晨, 曹尚超. 三维动脉自旋标记联合动态对比增强MRI对脑胶质瘤术后复发及放射性脑坏死诊断的研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 262-265.
[11] 张懿炜, 胡亚欣, 出良钊, 严昭, 曾茜, 蒲茜. CREB3通过下调FAK磷酸化水平抑制胶质瘤细胞增殖及侵袭转移的体外实验研究[J]. 中华临床医师杂志(电子版), 2023, 17(02): 202-209.
[12] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[13] 李民昌, 马长林. 自噬调控的细胞铁死亡及在肿瘤中影响的研究进展[J]. 中华诊断学电子杂志, 2023, 11(02): 140-144.
[14] 李正达, 张艳兵, 刘茂霞, 李玉芳, 杨新静. 艾司洛尔对脓毒症肠损伤的保护作用及对自噬蛋白AMPK表达水平的影响[J]. 中华卫生应急电子杂志, 2023, 09(02): 90-95.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要